Please ensure Javascript is enabled for purposes of website accessibility

Today's 3 Worst Stocks

By John Divine - Apr 22, 2013 at 7:14PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Biotech, the medical-devices industry, and IT all share one thing in common today: big-time losers.

We're smack-dab in the middle of earnings season -- a time of year when you can be sure to see a lot of sudden movements in the market. Although the S&P 500 Index (^GSPC -0.46%) added 7 points -- or 0.5% -- today, three of the 500 components distinguished themselves because of their poor performance on Monday, not their bullish movements.

The first of today's laggards, Alexion Pharmaceuticals (ALXN), lost 2.3% just a few days before it's set to report quarterly earnings on Thursday. The $18 billion Alexion is primarily driven by the success of its Soliris drug, which treats a rare disease known as paroxysmal nocturnal hemoglobinuria. Behind the success of Soliris, Alexion revenues rose 45% in 2012. However, the company's business model is so one-dimensional that my colleague Sean Williams worries it will have to exceed estimates by at least 10% to maintain current price levels. 

One of the most successful innovators in the field of medical technology in recent years, Intuitive Surgical (ISRG 1.40%), saw shares drop 2% Monday. Investors continued to sell off shares in the company after last week's earnings report, which depicted unimpressive growth in surgeries performed by Intuitive Surgical's moneymaker, the da Vinci robot. Trading at about 28 times earnings, the 23% sales growth and 31% net income growth didn't quite meet expectations. 

The last of today's underperformers, Cognizant Technology Solutions (CTSH 0.74%), was mainly in the red because of fallout from another information technology mainstay IBM (NYSE: IBM). Cognizant doesn't report earnings until May 8, but the fact that IBM slipped more than 8% Friday -- its worst performance in more than eight years -- doesn't bode well for the health of the IT industry. Since Big Blue is still a nearly undisputed leader in IT, its disappointing results alone are enough to precipitate a drop in Cognizant shares.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

S&P 500 Index - Price Return (USD) Stock Quote
S&P 500 Index - Price Return (USD)
^GSPC
$3,905.56 (-0.46%) $-18.12
Intuitive Surgical, Inc. Stock Quote
Intuitive Surgical, Inc.
ISRG
$218.37 (1.40%) $3.02
Alexion Pharmaceuticals, Inc. Stock Quote
Alexion Pharmaceuticals, Inc.
ALXN
Cognizant Technology Solutions Corporation Stock Quote
Cognizant Technology Solutions Corporation
CTSH
$70.75 (0.74%) $0.52

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
328%
 
S&P 500 Returns
116%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.